Andrew R. Robbins

This profile gathers the share dealings of Andrew R. Robbins across 3 companies, led by Array Biopharma Inc, Cogent Biosciences, Inc. and Harpoon Therapeutics, Inc. We count 31 filings; the first trade dates from 1 April 2017 and the latest from 19 May 2026.

Every open-market trade on record is a sale: 3 sales worth €7.1M. Besides market trades, the filings include 11 share grants and 12 option exercises.

The latest filing, published on 21 May 2026, reports a transaction in Cogent Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.